World Health Organization. (2019). International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). Geneva: WHO.
[2]
American Academy of Pediatrics. (2022). Management of Neonatal Hyperbilirubinemia. Pediatrics, 150(3), e2022058573.
[3]
Korst, L.M., & Gregory, K.D. (2021). Maternal and Neonatal Endocrine Disorders. In Creasy and Resnik's Maternal-Fetal Medicine (8th ed.). Philadelphia: Elsevier.
[4]
Sperling, M.A. (2020). Pediatric Endocrinology (5th ed.). Philadelphia: Elsevier.
[5]
Polak, M., & Leger, J. (2022). Neonatal Endocrine Disorders. In Pediatric Endocrinology (pp. 45-78). Springer Nature.
[6]
Rozance, P.J., & Hay, W.W. (2021). Describing Hypoglycemia in Neonates: Time to Standardize. Journal of Pediatrics, 235, 12-15.
[7]
Fraser, N., & Hussain, K. (2020). Transient Neonatal Hyperinsulinism. In Neonatal Endocrinology (pp. 89-112). Cambridge University Press.
[8]
Van Wassenaer, A.G. (2021). Thyroid Function in Preterm Infants. Pediatric Research, 89(7), 1658-1664.
[9]
Committee on Fetus and Newborn, American Academy of Pediatrics. (2023). Postnatal Glucose Homeostasis in Late Preterm and Term Infants. Pediatrics, 151(2), e2022059285.
[10]
Williams, A.F. (2022). Neonatal Hypoglycemia: From Observation to Intervention. Neonatology, 119(4), 432-440.